This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

BSX, AET, BAX, MDT And UNH, Pushing Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average (^DJI) trading down 126 points (-0.8%) at 15,723 as of Friday, Jan. 31, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,087 issues advancing vs. 1,837 declining with 186 unchanged.

The Health Services industry currently sits down 0.7% versus the S&P 500, which is down 0.5%. On the negative front, top decliners within the industry include Hanger (HGR), down 14.3%, C.R. Bard (BCR), down 2.5%, Intuitive Surgical (ISRG), down 1.6%, CareFusion (CFN), down 1.5% and Fresenius Medical Care AG & Co. KGaA (FMS), down 1.5%. A company within the industry that increased today was HCA Holdings (HCA), up 1.2%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Boston Scientific (BSX) is one of the companies pushing the Health Services industry lower today. As of noon trading, Boston Scientific is down $0.11 (-0.8%) to $13.45 on light volume. Thus far, 3.7 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 10.9 million shares. The stock has ranged in price between $13.30-$13.47 after having opened the day at $13.40 as compared to the previous trading day's close of $13.56.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $17.6 billion and is part of the health care sector. Shares are up 9.7% year-to-date as of the close of trading on Thursday. Currently there are 7 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Boston Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Submit an article to us!
DOW 16,539.46 -23.84 -0.14%
S&P 500 1,929.04 -1.63 -0.08%
NASDAQ 4,360.3590 -9.4140 -0.22%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs